Cytiva has collaborated with BioMelbourne Network to create a webinar showcasing the promising industry researchers and companies who finished in the top four places in Cytiva’s ANZ BioChallenge.

The event will include a panel discussion exploring the challenges in developing therapeutics and possible ways to overcome these. Stuart Newman from Therapeutic Innovation Australia and Jarrod Belcher from MTPConnect will also give attendees a glimpse of funding and grant opportunities to come this year for the biotech industry.

Register for this event below. Registration is free of charge.

Please send your questions to megan.gaudry@cytiva.com ahead of time for this webinar.

Event details

Date: Wednesday 30 March 2022
Time: 1:00pm – 2:00pm (Presentations and panel)
Format: Online via Zoom Webinar
Registration: Free

Guest speakers:

The winners:
David Haylock PhD, CEO, VivaZome Therapeutics
Brenton Hamdorf PhD, Director, Strategic Research Initiatives, Macquarie University
Kjesten Wiig PhD, Director of Strategic Partnerships, Malaghan Institute of Medical Research
Sushil Gupta M.Sc, Head, Process Development, NeuClone

Funding and grant opportunities presentation:
Jarrod Belcher BSc, Director Researcher Exchange and Development within Industry Initiative, MTPConnect
Stuart Newman PhD GAICD, CEO, Therapeutic Innovation Australia

On the panel:
Tim O’Meara PhD, Government and Research Strategy Manager ANZ, Cytiva
Stephen O’Sullivan BASc, Business Development Enterprise Solutions Manager ANZ, Cytiva
David Haylock PhD, CEO, VivaZome Therapeutics
Brenton Hamdorf PhD, Director, Strategic Research Initiatives, Macquarie University
Sushil Gupta M.Sc, Head, Process Development, NeuClone
Kjesten Wiig PhD, Director of Strategic Partnerships, Malaghan Institute of Medical Research

Host and facilitator:
Janelle Bryce BSc, Marketing Leader ANZ, Cytiva

About the ANZ BioChallenge

In 2021 Cytiva launched the ANZ BioChallenge support program to help biotech researchers and companies to overcome obstacles in biologic manufacturing. The competition attracted 32 proposals from academic institutions and start-up companies across the region’s biotechnology industry. The focus was on empowering biotech researchers and companies in three areas: cell engineering, process development and isolation as well as chromatography and filtration purification.

About Cytiva

Cytiva is a global life sciences leader that works with academic and translational researchers, developers, and manufacturers of biotherapeutics, cell and gene therapies, and new technologies such as mRNA, to enable the delivery of transformative medicines. Cytiva is a trusted expert with nearly 10 000 associates in more than 40 countries dedicated to customers’ speed, flexibility, capacity and efficiency in drug discovery, research, and manufacturing. Visit cytiva.com for more.

 

Delivered in collaboration with Cytiva